EDITORIAL
Published on 09 Feb 2024
Editorial: Repurposing β-blockers for non-cardiovascular diseases
doi 10.3389/fphar.2024.1372317
- 983 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Repurposing β-blockers for non-cardiovascular diseases
Repurposing β-blockers for non-cardiovascular diseases
3,389
Total downloads
12k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 09 Jan 2024
Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
doi 10.3389/fphar.2023.1325050
- 2,341 views
- 1 citation
ORIGINAL RESEARCH
Published on 27 Nov 2023
Association between antihypertensive drugs and oral cancer: a drug target Mendelian randomization study
doi 10.3389/fphar.2023.1294297
- 2,815 views
- 4 citations
ORIGINAL RESEARCH
Published on 26 Oct 2023
Association between the β-blocker use and patients with sepsis: a cohort study
doi 10.3389/fmed.2023.1272871
- 2,656 views
- 6 citations
ORIGINAL RESEARCH
Published on 19 May 2023
Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)
doi 10.3389/fphar.2023.1137791
- 1,632 views
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Neuropharmacology
- Cardiovascular and Smooth Muscle Pharmacology
- Inflammation Pharmacology
Participating Journals
Frontiers in Immunology
Inflammation PharmacologyOffline
- 5.7 impact factor
- 9.8 citescore
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Frontiers in Psychiatry
NeuropharmacologyOffline
- 3.2 impact factor
- 6.2 citescore
Impact
- 12kTopic views
- 8,181Article views
- 3,389Article downloads